June 26, 2023
Laboratory will enable visualization of biological molecules in unprecedented detail and at scale, providing the company with a competitive advantage in the de novo therapeutic protein field SOMERVILLE, Mass. – Generate:Biomedicines today announced the unveiling of its cryogenic electron microscopy (CryoEM) laboratory in Andover, Massachusetts. Among the largest privately-owned CryoEM laboratories in the United States, this 70,000 sq ft site will enable [...]
June 26, 2023
Chip-A1 allows researchers to effectively model complex 3D tissues, such as the tumor microenvironment and skin, with direct compound dosing capabilities. Boston, MA – Emulate, Inc., the leading provider of next-generation in vitro models, today announced the launch of the Emulate Chip-A1™ Accessible Chip through an early access program. This new Organ-Chip design expands on the original [...]
June 26, 2023
CHENGDU, China -- HitGen Inc. ("HitGen", SSE: 688222.SH) has recently launched a newly upgraded version of its OpenDEL™ product, a self-service screening kit for novel molecules. It contains 65% more DEL libraries than the previous version, and with over 3 billion compounds. The 2-cycle and 3-cycle libraries in the kit are designed with excellent drug-like properties. [...]
June 26, 2023
Mirna Jarosz, formerly General Manager of Integrated DNA Technology's (IDT) NGS business will focus on driving customer success, strategy and commercial focus as Head of Product Strategy Shlomey Derhi, former head of R&D for a large group within the Israel Defense Forces will focus on accelerating technology development as Head of Architecture and Integration FREMONT, [...]
June 26, 2023
Peabody and Andover, MA - Two towering JEOL Electron Microscopes stand ready to produce terabytes of valuable data for researchers at Generate:Biomedicines each day, who are accelerating drug discovery and development of novel therapeutics using machine learning and generative artificial intelligence. The two Transmission Electron Microscopes, the JEOL CRYO ARM 200 and CRYO ARM 300 [...]
June 26, 2023
Agreements with Vizgen, Resolve Biosciences, and Ultivue expand end-to-end, large-scale, deep molecular profiling and custom data analytics services offering LEUVEN, Belgium -- OMAPiX, a leading provider of spatial omics services and custom data analytics, today announced strategic partnerships with Vizgen, Inc., Resolve Biosciences, and Ultivue, Inc. As part of the agreements, OMAPiX scientists will use [...]
Strengthen Stirling Refrigeration Technology
June 25, 2023
In order to continue to enhance the Stirling refrigeration technology barriers, and to achieve independent control of core components, expand the business layout of the cryogenic field, Haier Biomedical released an announcement on the evening of June 7, the company intends to use its own funds of $6 million USD in the form of installment [...]
Eppendorf Award for Young European Investigators 2023 goes to Maurice Michel, Sweden
June 23, 2023
Hamburg -- This year, the Hamburg based life sciences company Eppendorf SE is awarding its prestigious research prize for the 28th time. The independent jury chaired by Prof. Reinhard Jahn selected Dr. Maurice Michel, Science for Life Laboratory, Karolinska Institutet, Stockholm, Sweden as the winner of the Eppendorf Award for Young European Investigators 2023 Maurice [...]
Stirling Ultracold Upright ULT Freezer ISO Class 6 Approved for Cleanroom Applications
June 23, 2023
We are pleased to announce that the SU780XLE Ultra-Low Temperature (ULT) Freezer has been tested and certified by Underwriter Laboratories (UL) to meet the International Organization for Standardization (ISO) Class 6 cleanroom standard (ISO 14644-14:2016). This ensures that our upright freezer meets the stringent requirements for air cleanliness in critical cleanroom and associated controlled environments, such [...]
Abcam Announces Review of Strategic Alternatives
June 23, 2023
Cambridge, UK / Waltham, MA: Abcam plc (“Abcam,” “Company,” “Group”) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces that, having listened to and extensively engaged with shareholders, the Board of Directors has unanimously decided to initiate a process to explore strategic alternatives for the Company. The comprehensive process [...]
